Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF654 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SMARCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAN2A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP1B3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2C1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SLC44A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA0040 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V0C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPUSD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARNP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCG18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OCLN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on